HANNIBAL THERAPEUTICS AS
Operating
Utvikling av legemidler mot alvorlige sykdommer.
Organization
- CEO
- BH
Bjarte Håvik1970
- Chairman of the board
- BH
Bjarte Håvik1970
- Years since formation
- 1 year
- since May 26, 2025
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Financials
- Annual total result 2025
- -6,318
- NOK
- Total equity 2025
- 17,183
- NOK
Last update: Jun 30, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
BH 1970 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
BH 1970 | Chairman | - |
Last update: May 26, 2025
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -6,318 |
Total assets | 17,183 |
Total liabilities | 0 |
Total equity | 17,183 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 6,318 |
Operating result | -6,318 |
Financial income/costs | 0 |
Profit before tax | -6,318 |
Total tax & extraordinary income/cost | 0 |
Annual Total Result | -6,318 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 0 |
Total current assets | 17,183 |
Total assets | 17,183 |
Short term debt | 0 |
Long term debt | 0 |
Total liabilities | 0 |
Contributed capital | 23,500 |
Retained earnings | -6,317 |
Total equity | 17,183 |
Total equity and liabilities | 17,183 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises